The MarketWatch News Department was not involved in the creation of this content. AURORA, Colo., Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class ...
Denver-based RheumaGen has raised $15 million in series A financing to develop gene therapies for autoimmune disease. The start-up’s lead drug candidate precisely edits a dysfunctional human leukocyte ...
A new study led by Profs. Xu Tao and He Shunmin from the Institute of Biophysics of the Chinese Academy of Sciences has revealed how human leukocyte antigen (HLA) genes, central to the immune system, ...
The HLA-B27 genetic marker is known to be associated with increased risk for various arthropathies, including JIA. Whether the genetic marker's presence has prognostic value has been uncertain. In ...
A debilitating autoimmune condition silently attacks the spine and surrounding joints, causing inflammation that gradually transforms flexible vertebrae into rigid, fused bone. Ankylosing spondylitis ...
Two human leukocyte antigen (HLA) alleles, DRB1*04.04 and DRB1*03, show a significant correlation with myasthenia gravis (MG) prevalence. Northern Europe exhibits the highest prevalence of MG and ...
Neuberg notes autoimmune diseases on the rise in driven by stress, poor sleep, sedentary lifestyle: Our Bureau, Bengaluru Monday, April 20, 2026, 16:30 Hrs [IST] Neuberg Diagnosti ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results